Cite
HARVARD Citation
Spigel, D. et al. (2019). A Randomized, Double‐Blinded, Phase II Trial of Carboplatin and Pemetrexed with or without Apatorsen (OGX‐427) in Patients with Previously Untreated Stage IV Non‐Squamous‐Non‐Small‐Cell Lung Cancer: The SPRUCE Trial. Oncologist. pp. e1409-e1416. [Online].